ADRIANA GIRARD: Open Payments
NPI 1982326617 · RUTHERFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,890 in 89 payments from 14 companies in 2025. Trend: 2023 $1,165 · 2024 $1,985 · 2025 $1,890
Food & beverage: $1,791Education: $99
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 24 | $468 |
| ABBVIE INC. | 16 | $289 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $234 |
| Galderma Laboratories, L.P. | 14 | $189 |
| Lilly USA, LLC | 4 | $175 |
| Janssen Biotech, Inc. | 4 | $158 |
| LEO Pharma Inc. | 4 | $72 |
| Incyte Corporation | 4 | $71 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Amgen Inc. | 3 | $54 |
Products named: Zoryve, TREMFYA, NEMLUVIO, EBGLYSS, BOTOX, SKYRIZI, Opzelura, ILUMYA.
Industry payments across NJ — which companies pay providers there.
